Mailed FIT Outreach 2022

Completed · Not applicable

Conditions studied: Colorectal Cancer, Colon Cancer

In brief

This project aims to evaluate different approaches to increase colorectal cancer screening among primary care patients at Penn Medicine through a centralized screening outreach program. In a pragmatic trial, we will evaluate different approaches to increase response rate to mailed fecal immunochemical test (FIT) kits among eligible patients, including differentiated packaging, sending text reminders, and personalized reminders.

Key facts

Study ID

NCT05341622

Run by

Abramson Cancer Center at Penn Medicine

People needed

5460

Starts

2022-05-27

Expected to finish

2022-12-13

Last updated by the study team

2024-07-24

Who can join

Age: 50 and older, up to 74. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients ages 50-74 with Penn as preferred lab
• Followed by Primary Care with a participating Penn Medicine PCP listed and at least one visit in the last 2 years
• Not up to date on colorectal cancer screening per Health Maintenance (no colonoscopy in the last 10 years, stool testing in the last year, flexible sigmoidoscopy in the last 5 years, FIT-DNA in the last 3 years).

You may not qualify if…

• Personal or significant family history of CRC, colonic polyps, hereditary nonpolyposis colorectal cancer syndrome, familial adenomatous polyposis syndrome, other gastrointestinal cancer, gastrointestinal bleeding, iron-deficiency anemia, or inflammatory bowel disease
• History of total colectomy, dementia or metastatic cancer
• Currently on hospice or receiving palliative care
• Uninsured or self-pay patients
• Currently scheduled for a colonoscopy or sigmoidoscopy

Where it is running

• Penn Medicine — Philadelphia, Pennsylvania, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.